Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xi Zhao

Showing results (1001-1010 of 1,015) with videos related to

Pageof 102
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 2023
A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinomaYong-Qiao He, Tong-Min Wang, Da-Wei Yang, et al.
Infectious Diseases of Poverty|November 26, 2020
Increased circulating level of interleukin-6 and CD8<sup>+</sup> T cell exhaustion are associated with progression of COVID-19Peng-Hui Yang, Yi-Bo Ding, Zhe Xu, et al.
Translational Lung Cancer Research|October 17, 2022
Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancerDan-Hua Li, Yong-Qiao He, Tong-Min Wang, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Cell|June 22, 2026
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistanceGuang Lei, Zhengze Lu, Zhihao Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2024
Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)Chen Li, Yantao Tian, Yanan Zheng, et al.
Molecular Ecology Resources|May 12, 2019
A chromosome-level genome of black rockfish, Sebastes schlegelii, provides insights into the evolution of live birthYan He, Yue Chang, Lisui Bao, et al.
Blood|May 3, 2024
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignanciesChewei Anderson Chang, Ethan Emberley, Aloma L D'Souza, et al.
American Journal of Human Genetics|June 23, 2023
High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinomaTong-Min Wang, Ruo-Wen Xiao, Yong-Qiao He, et al.
The Lancet. Respiratory Medicine|July 22, 2019
Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populationsJuncheng Dai, Jun Lv, Meng Zhu, et al.
Pageof 102

Showing results (1001-1010 of 1,015) with videos related to

Sort By:
Pageof 102
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 2023
A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinomaYong-Qiao He, Tong-Min Wang, Da-Wei Yang, et al.
Infectious Diseases of Poverty|November 26, 2020
Increased circulating level of interleukin-6 and CD8<sup>+</sup> T cell exhaustion are associated with progression of COVID-19Peng-Hui Yang, Yi-Bo Ding, Zhe Xu, et al.
Translational Lung Cancer Research|October 17, 2022
Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancerDan-Hua Li, Yong-Qiao He, Tong-Min Wang, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Cell|June 22, 2026
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistanceGuang Lei, Zhengze Lu, Zhihao Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2024
Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)Chen Li, Yantao Tian, Yanan Zheng, et al.
Molecular Ecology Resources|May 12, 2019
A chromosome-level genome of black rockfish, Sebastes schlegelii, provides insights into the evolution of live birthYan He, Yue Chang, Lisui Bao, et al.
Blood|May 3, 2024
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignanciesChewei Anderson Chang, Ethan Emberley, Aloma L D'Souza, et al.
American Journal of Human Genetics|June 23, 2023
High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinomaTong-Min Wang, Ruo-Wen Xiao, Yong-Qiao He, et al.
The Lancet. Respiratory Medicine|July 22, 2019
Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populationsJuncheng Dai, Jun Lv, Meng Zhu, et al.
Pageof 102